Akeso, Inc.: New Drug Application for Cadonilimab (PD-1/CTLA

Akeso, Inc.: New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA

Akeso, Inc.: New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Xia Yu , Wu Xiaohua , Prnewswire Akeso Inc , National Medical Products Administration , Fudan University Cancer Hospital , Akeso Inc , சீனா , கிஷிய யூ ,